Francesca Galardi

2.4k total citations
46 papers, 1.8k citations indexed

About

Francesca Galardi is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Francesca Galardi has authored 46 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 23 papers in Cancer Research and 15 papers in Molecular Biology. Recurrent topics in Francesca Galardi's work include Cancer Genomics and Diagnostics (17 papers), Advanced Breast Cancer Therapies (11 papers) and Cancer Cells and Metastasis (11 papers). Francesca Galardi is often cited by papers focused on Cancer Genomics and Diagnostics (17 papers), Advanced Breast Cancer Therapies (11 papers) and Cancer Cells and Metastasis (11 papers). Francesca Galardi collaborates with scholars based in Italy, United States and Belgium. Francesca Galardi's co-authors include Cristina Gonnelli, R. Gabbrielli, Alessio Mengoni, Angelo Di Leo, Marco Bazzicalupo, Francesca De Luca, Marta Pestrin, Laura Biganzoli, Chiara Biagioni and Luca Malorni and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Francesca Galardi

44 papers receiving 1.8k citations

Peers

Countries citing papers authored by Francesca Galardi

Since Specialization

Citations

This map shows the geographic impact of Francesca Galardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Galardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Galardi more than expected).

Fields of papers citing papers by Francesca Galardi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Galardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Galardi. The network helps show where Francesca Galardi may publish in the future.

Co-authorship network of co-authors of Francesca Galardi

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Galardi. A scholar is included among the top collaborators of Francesca Galardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Galardi. Francesca Galardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	52P Dynamics of ctDNA and serum thymidine kinase activity in patients with ER+/HER2- metastatic breast cancer receiving abemaciclib vs palbociclib or ribociclib: Early results of the TIRESIAS trial 2025 ·ESMO Open ·(unknown), Francesca Galardi, (unknown), Massimo De Paoli, Dario Romagnoli, (unknown), Grazia Arpino, (unknown), Luca Gianni, (unknown), (unknown), C. Zamagni, Piero Poletti, Anna Cariello, Cristina Guarducci, Ilenia Migliaccio, Emanuela Risi, Matteo Benelli, Laura Biganzoli, (unknown)	0
2	Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer Receiving Palbociclib: Results From the TREnd Trial 2024 ·JCO Precision Oncology ·Ilenia Migliaccio, Dario Romagnoli, Francesca Galardi, Francesca De Luca, Chiara Biagioni, Giuseppe Curigliano, Carmen Criscitiello, Alessandro Marco Minisini, Erica Moretti, Emanuela Risi, Cristina Guarducci, Agostina Nardone, Laura Biganzoli, Matteo Benelli, Luca Malorni	4
3	MIMESIS: minimal DNA-methylation signatures to quantify and classify tumor signals in tissue and cell-free DNA samples 2023 ·Briefings in Bioinformatics ·Dario Romagnoli, Agostina Nardone, Francesca Galardi, (unknown), Francesca De Luca, Chiara Biagioni, Gian Marco Franceschini, Marta Pestrin, Giuseppina Sanna, Erica Moretti, Francesca Demichelis, Ilenia Migliaccio, Laura Biganzoli, Luca Malorni, Matteo Benelli	1
4	2272P Minimal DNA-methylation (DNAm) signatures for non-invasive tumor-agnostic estimation of tumor content (TC) and molecular subtype in patients (pts) with metastatic breast cancer (mBC) 2023 ·Annals of Oncology ·Matteo Benelli, Antonio Nardone, Francesca Galardi, Dario Romagnoli, Francesca De Luca, (unknown), Massimo De Paoli, Ilenia Migliaccio, Marta Pestrin, Giuseppina Sanna, Emanuela Risi, Luca Livraghi, Erica Moretti, Chiara Biagioni, Luca Malorni, Laura Biganzoli	1
5	Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast Cancer 2021 ·Cancers ·Ilenia Migliaccio, Angela Leo, Francesca Galardi, Cristina Guarducci, (unknown), Matteo Benelli, Angelo Di Leo, Laura Biganzoli, Luca Malorni	8
6	Circulating tumor cells and palbociclib treatment in patients with ER-positive, HER2-negative advanced breast cancer: results from a translational sub-study of the TREnd trial 2021 ·Breast Cancer Research ·Francesca Galardi, Francesca De Luca, Chiara Biagioni, Ilenia Migliaccio, Giuseppe Curigliano, Alessandro Marco Minisini, Martina Bonechi, Erica Moretti, Emanuela Risi, Amelia McCartney, Matteo Benelli, Dario Romagnoli, Silvia Cappadona, (unknown), Cristina Guarducci, Valerio Conti, Laura Biganzoli, Angelo Di Leo, Luca Malorni	25
7	Plasma Thymidine Kinase Activity as a Biomarker in Patients with Luminal Metastatic Breast Cancer Treated with Palbociclib within the TREnd Trial 2020 ·Clinical Cancer Research ·Amelia McCartney, Martina Bonechi, Francesca De Luca, Chiara Biagioni, Giuseppe Curigliano, Erica Moretti, Alessandro Marco Minisini, Mattias Bergqvist, Matteo Benelli, Ilenia Migliaccio, Francesca Galardi, Emanuela Risi, Irene De Santo, Dario Romagnoli, Laura Biganzoli, Angelo Di Leo, Luca Malorni	37
8	The challenge of sustainability in healthcare systems: economic and organizational impact of subcutaneous formulations for rituximab and trastuzumab in onco-hematology 2020 ·Expert Review of Pharmacoeconomics & Outcomes Research ·Mattia Altini, (unknown), (unknown), Gerardo Musuraca, Roberta Maltoni, Carla Masini, Francesca Galardi, (unknown), Ilaria Massa	11
9	Prognostic role of serum thymidine kinase 1 activity in patients with hormone receptor–positive metastatic breast cancer: Analysis of the randomised phase III Evaluation of Faslodex versus Exemestane Clinical Trial (EFECT) 2019 ·European Journal of Cancer ·Amelia McCartney, Chiara Biagioni, Gaia Schiavon, Mattias Bergqvist, Karin Mattsson, Ilenia Migliaccio, Matteo Benelli, Dario Romagnoli, Martina Bonechi, Giulia Boccalini, Marta Pestrin, Francesca Galardi, Francesca De Luca, Laura Biganzoli, Martine Piccart, William J. Gradishar, Stephen Chia, Angelo Di Leo, Luca Malorni	25
10	Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients 2014 ·Molecular Oncology ·Marta Pestrin, Francesca Salvianti, Francesca Galardi, Francesca De Luca, Natalie Turner, Luca Malorni, Mario Pazzagli, Angelo Di Leo, Pamela Pinzani	135
11	Molecular Analysis of Single Circulating Tumor Cells (CTCS) Isolated from Metastatic Breast Cancer (MBC) Patients (PTS) 2013 ·Annals of Oncology ·Marta Pestrin, Francesca Galardi, Francesca Salvianti, Francesca De Luca, Silvia Bessi, (unknown), Angelo Di Leo, A. James Giannini, Pamela Pinzani, Mario Pazzagli	2
12	Inter- and intra-tumoral heterogeneity in DNA damage evaluated by comet assay in early breast cancer patients 2012 ·The Breast ·Francesca Galardi, Catherine Oakman, (unknown), Silvia Cappadona, Annibale Biggeri, Laura Grisotto, Lisa Giovannelli, Silvia Bessi, A. James Giannini, Laura Biganzoli, Libero Santarpia, Angelo Di Leo	12
13	The role of topoisomerase IIα and HER-2 in predicting sensitivity to anthracyclines in breast cancer patients 2009 ·Cancer Treatment Reviews ·Catherine Oakman, Erica Moretti, Francesca Galardi, Libero Santarpia, Angelo Di Leo	25
14	Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients 2009 ·Breast Cancer Research and Treatment ·Marta Pestrin, Silvia Bessi, Francesca Galardi, (unknown), Annibale Biggeri, Chiara Biagioni, Silvia Cappadona, Laura Biganzoli, A. James Giannini, Angelo Di Leo	169
15	Recent advances in systemic therapy. New diagnostics and biological predictors of outcome in early breast cancer 2009 ·Breast Cancer Research ·Catherine Oakman, Silvia Bessi, Elena Zafarana, Francesca Galardi, Laura Biganzoli, Angelo Di Leo	59
16	Isolation and Characterization of Endophytic Bacteria from the Nickel Hyperaccumulator Plant Alyssum bertolonii 2007 ·Microbial Ecology ·(unknown), (unknown), Marco Bazzicalupo, R. Gabbrielli, Francesca Galardi, Cristina Gonnelli, Alessio Mengoni	150
17	Arsenate tolerance in Silene paradoxa does not rely on phytochelatin-dependent sequestration 2007 ·Environmental Pollution ·Miluscia Arnetoli, Riet Vooijs, (unknown), Francesca Galardi, Cristina Gonnelli, R. Gabbrielli, Henk Schat, Jos A.C. Verkleij	36
18	Genetic diversity inferred from AFLP fingerprinting in populations of Onosma echioides (Boraginaceae) from serpentine and calcareous soils 2006 ·Plant Biosystems - An International Journal Dealing with all Aspects of Plant Biology ·Alessio Mengoni, Federico Selvi, (unknown), Francesca Galardi, Cristina Gonnelli	42
19	Evolutionary dynamics of nickel hyperaccumulation in Alyssum revealed by its nrDNA analysis 2003 ·New Phytologist ·Alessio Mengoni, Alan J. M. Baker, Marco Bazzicalupo, Roger D. Reeves, Nezaket Adıgüzel, (unknown), Francesca Galardi, R. Gabbrielli, Cristina Gonnelli	57
20	Chloroplast genetic diversity and biogeography in the serpentine endemic Ni‐hyperaccumulator Alyssum bertolonii 2003 ·New Phytologist ·Alessio Mengoni, Cristina Gonnelli, (unknown), Francesca Galardi, Sabina Pucci, R. Gabbrielli, Marco Bazzicalupo	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact